Search results (48)
« Back to NewsThe latest news, stories and exciting findings from across the Oxford cancer research community
University of Oxford unveils new vaccine development partnership
15 November 2024
Oxford Cancer, the Oxford Vaccine Group and the Pandemic Sciences Institute have announced a new collaboration with Belgian Biotech Innovator, Univercells.
2024 OCION Pump Prime Awardees Named
14 November 2024
Congratulations to the 2024 OCION Pump Prime Awardees, funded by the CRUK Oxford Centre and NIHR Oxford BRC
COMBATcancer at the HIPP Summer School 2024
1 November 2024
Aleksandra Dzhoneva - Postdoctoral Scientist- shares her experience at the HIPP Summer School 2024, which she attended to present research as part of the COMBATcancer consortium. Her attendance was fully funded by Oxford Cancer.
Dr Bo Sun awarded Future Leaders Grant
15 October 2024
The three-year £225,000 grant from The Brain Tumour Charity will fund research into whether it's possible to use T-cells to track and detect gliomas.
OCION: In conversation with Alfred Zippelius
7 October 2024
Through the Oxford Cancer Immuno-Oncology Network (OCION), we aim to apply Oxford's leading expertise in fundamental immunology to enable more patients, with a wide range of cancer types, to benefit safely from tailored immunotherapy use. We sat down with Professor Alfred Zippelius to discuss his research.
OCION: In conversation with Ignacio Melero
11 September 2024
Through the Oxford Cancer Immuno-Oncology Network (OCION), we aim to apply Oxford's leading expertise in fundamental immunology to enable more patients, with a wide range of cancer types, to benefit safely from tailored immunotherapy use. We sat down with Professor Ignacio Melero to discuss his research.
The great escape artist – how tracking co-evolution could improve immunotherapy
26 July 2024
Tumour cells escaping the immune system is a major cause of resistance to cancer immunotherapy. So how can we stop it? Audrey Gérard sat down with CRUK to discuss...
OCION: In conversation with Felipe Galvez-Cancino
5 July 2024
Through the Oxford Cancer Immuno-Oncology Network (OCION), we aim to apply Oxford's leading expertise in fundamental immunology to enable more patients, with a wide range of cancer types, to benefit safely from tailored immunotherapy use. We sat down with Professor Felipe Galvez-Cancino, who has recently joined the Nuffield Department of Medicine, to discuss his research.
OCION: In conversation with Dave Withers
17 June 2024
Through the Oxford Cancer Immuno-Oncology Network (OCION), we aim to apply Oxford's leading expertise in fundamental immunology to enable more patients, with a wide range of cancer types, to benefit safely from tailored immunotherapy use. We sat down with Professor David Withers, who recently moved to Oxford, to discuss his research.
Immunotherapy: finding hidden ways to treat cancer
13 June 2024
Giamp Valenzano, a DPhil in Cancer Science student, joins forces with Oxford Sparks to deliver a video explaining how his research on immunotherapy aims to help treat cancer
Oxford Cancer Immuno-Oncology Network 2024 Symposium
10 June 2024
Fantastic day of immuno-oncology talks and networking at this years' annual OCION Symposium!
Immune cells hunt down cancer around the body – discovery could lead to personalised treatments for advanced breast cancer
2 May 2024
Scientists have discovered the key features of immune B cells which make them successful at targeting tumours – including when cancer has spread to a different part of the body.
New study reveals how T cells gain and maintain tolerance to gut bacteria
10 April 2024
The immune system in the intestine maintains a careful balance, tolerating our long-term resident (commensal) gut bacteria while defending against invading pathogens. Under certain circumstances, dysregulation of our intestinal immune response to commensal and pathogenic microbes can drive inflammatory disease.
OCION: In conversation with Tim Elliott
28 March 2024
Through the Oxford Cancer Immuno-Oncology Network (OCION), we aim to realise the long-term curative benefits of immunotherapy for more patients by devising new treatments, broadening the impact of existing treatments, and reducing side effects. We sat down with Director, Tim Elliott, to discuss further.
£1.7 million for vaccine to prevent lung cancer
22 March 2024
Oxford and UCL researchers seeking to create the world’s first vaccine to prevent lung cancer in people at high risk of the disease have been granted up to £1.7 million from Cancer Research UK and the CRIS Cancer Foundation.
OCION Funding Scheme: In conversation with Alistair Easton
23 February 2024
The mission of the Oxford Cancer Immuno-Oncology Network (OCION) Funding Scheme is to pump-prime innovative Oxford-based immuno-oncology research and build capacity in cancer immunology. We sat down with 2023 awardee, Alistair Easton, to discuss what research the fund will enable him to carry out.
CRUK funding success for Audrey Gérard
14 February 2024
Audrey Gérard has received £ 1.5 million in funding from CRUK for a new research project to unravel the coevolving cancer and immune landscape.
New study provides framework for optimising the design of antibody therapeutics
13 February 2024
New research has uncovered how antibodies trigger immune receptors in T cells. This breakthrough provides an improved framework for designing therapeutic antibodies, which could be used in new and better therapies for cancer and autoimmune diseases.
World Cancer Day: Oxford University professors on the record with their contribution to the fight against cancer
4 February 2024
Principal Investigators at the University talk candidly about their work and how they’re helping the fight against cancer.
AI-based method provides insights for predicting colorectal cancer outcomes
2 February 2024
The largest multiparameter immunoprofiling study in cancer to date has suggested an underappreciated role of a subset of immune cells in determining the risk of bowel cancer relapse after surgery.